UHS Universal Health Services, Inc. Common Stock
NYSE · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 7, 2026UHS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
UHS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2009年12月16日 | 2-for-1 | 正向 |
| 2001年6月4日 | 2-for-1 | 正向 |
| 1996年5月20日 | 2-for-1 | 正向 |
| 1983年7月5日 | 2-for-1 | 正向 |
关于 Universal Health Services, Inc. Common Stock 公司概况(来自维基百科)
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Company history
Alan B. Miller, who currently serves as the company's Executive Chairman, founded Universal Health Services, Inc. in 1979. Within 18 months of its founding, UHS owned four hospitals and had management contracts with two additional hospitals.
In 1979, UHS entered Las Vegas with the purchase of Valley Hospital.
In 1980, the company chose its first Board of Directors. In 1981, UHS held its initial public offering. In 1982, UHS purchased five hospitals from the Stewards Foundation, marking the first time a for-profit corporation purchased hospitals from a nonprofit religious organization. In 1983, UHS purchased Qualicare, Inc. for more than $116 million. The purchase included 11 acute care hospitals and four behavioral health hospitals. In 1986, UHS created Universal Health Realty Income Trust, the first REIT in the healthcare industry.
In 1991, UHS stock trading moved from NASDAQ to NYSE.
In November 2010, UHS reached an agreement in May to acquire Psychiatric Solutions, Inc. for $3.1 billion. In June 2012, UHS announced its plans to acquire Ascend Health Corporation for $517 million. In February 2014, UHS bought Palo Verde Mental Health for an undisclosed amount, renaming the facility to Palo Verde Behavioral Health. In April of that year, UHS announced the acquisition of the Psychiatric Institute of Washington. In September of that year, UHS' stock joined the S&P 500 Index and acquired Cygnet Health Care Limited for approximately $335 million. In August 2015, UHS acquired Alpha Hospitals Holdings Limited for $148 million from private equity group C&C Alpha Group. In September of that year, UHS announced the acquisition of Foundations Recovery Network based in Brentwood, Tennessee for $350 million. In August 2016, UHS bought Desert View Hospital in Pahrump, Nevada for an undisclosed amount. In December of that year, UHS acquired Cambian Group PLC's Adult Services Division. In July 2018, UHS announced its acquisition of the Danshell Group.
On September 28, 2020, Universal Health Services Inc. announced that its network went offline after an unspecified "IT security issue".
In September 2020, consistent with the company's long-standing succession plan, UHS announced that Alan B. Miller would step down as CEO in January 2021 and that President Marc D. Miller would be named CEO.
UHS ranked on the Fortune 500 in 2021, 2022 in 2023 and 2024, and 2025
UHS was named on the Fortune World's Most Admired List in 2025, 2024 2023, 2022, 2021 and 2020.
UHS has been named on the Forbes Global 2000 ranking in 2025. UHS is ranked at #1,090. Of the American companies on the ranking, UHS ranked #355 among U.S. companies and #23 among global Health Care Equipment and Services category. UHS has been on the ranking for 22 years, and in 2023 earned ‘Hall of Fame’ status.
In March 2026, UHS agreed to acquire online and mobile therapy service provider Talkspace for $835 million.
Controversies
Hospital licenses
The Centers for Medicare and Medicaid Services (CMS) threatened the Rancho Springs Medical Center (Murrieta) and Inland Valley Regional Medical Center (Wildomar) in California with decertification in June 2010 while the State of California warned of a possible hospital license revocation. Universal Health Services implemented a program to address all concerns and in November 2011 the two hospitals passed a CMS Certification Survey. As a result, CMS rescinded its termination notice and the California Department of Public Health withdrew its license revocation notice.
Allegations of noncompliance with same-sex visitation law
According to a petition started on Change.org by Terri-Ann Simonelli of Henderson, Nevada, Spring Valley Hospital (owned and operated by UHS) claimed that their policy required power of attorney for a same-sex partner to make medical decisions on behalf of their partner. If true, this would seemingly violate new Department of Health and Human Services rules enabling same-sex partners to make said decisions, with or without power of attorney.
Fraudulent Medicaid claims
In September 2012, UHS and its subsidiaries, Keystone Education and Youth Services LLC and Keystone Marion LLC d/b/a Keystone Marion Youth Center agreed to pay over $6.9 million to resolve allegations that they submitted false and fraudulent claims to Medicaid. Between October 2004 and March 2010, the entities allegedly provided substandard psychiatric counseling and treatment to adolescents in violation of the Medicaid requirements. The United States alleged that UHS falsely represented Keystone Marion Youth Center as a residential treatment facility providing inpatient psychiatric services to Medicaid enrolled children, when in fact it was a juvenile detention facility. The United States further alleged that neither a medical director nor licensed psychiatrist provided the required direction for psychiatric services or for the development of initial or continuing treatment plans. The settlement further resolved allegations that the entities filed false records or statements to Medicaid when they filed treatment plans that falsely represented the level of services that would be provided to the patients.
On July 10, 2020, the US Department of Justice announced a $122 million Fraudulent Claims case with "Universal Health Services, Inc., UHS of Delaware, Inc.(together, UHS), and Turning Point Care Center, LLC (Turning Point), a UHS facility located in Moultrie, Georgia, have agreed to pay a combined total of $122 million to resolve alleged violations of the False Claims Act for billing for medically unnecessary inpatient behavioral health services, failing to provide adequate and appropriate services, and paying illegal inducements to federal healthcare beneficiaries." From the announcement: "The government alleged that, between January 2006, and December 2018, UHS's facilities admitted federal healthcare beneficiaries who were not eligible for inpatient or residential treatment because their conditions did not require that level of care, while also failing to properly discharge appropriately admitted beneficiaries when they no longer required inpatient care. The government further alleged that UHS's facilities billed for services not rendered, billed for improper and excessive lengths of stay, failed to provide adequate staffing, training, and/or supervision of staff, and improperly used physical and chemical restraints and seclusion. In addition, UHS's facilities allegedly failed to develop and/or update individual assessments and treatment plans for patients, failed to provide adequate discharge planning, and failed to provide required individual and group therapy services in accordance with federal and state regulations.
Of the $117 million to be paid by UHS to resolve these claims, the federal government will receive a total of $88,124,761.27, and a total of $28,875,238.73 will be returned to individual states, which jointly fund state Medicaid programs."
BuzzFeed investigation
On December 7, 2016, BuzzFeed published a report detailing questionable practices within UHS psychiatric facilities. The report includes allegations of holding nonthreatening patients against their will, manipulative misinterpretation of patient testimonies to fit guidelines to involuntary confinement, aggressive staff layoffs and understaffing in hospitals, needless patient deaths due to understaffing and misprescription of medication, "violating a patient's right to be discharged or holding a patient without the proper documentation", and unnecessary extension of stay times to the maximum Medicare payout. UHS denied the conclusions of the report. UHS stock fell approximately 12% after publication.
According to BuzzFeed investigative reporter Rosalind Adams, UHS responded to the report by hiring "a global PR firm that offers specialized crisis management services... UHS didn't just implement a crisis PR plan. It also fired an employee that the company believed to have spoken to a reporter; it sued a former employee it alleges leaked damaging internal surveillance videos; it threatened to sue other employees; at least one facility held a series of town hall meetings to warn employees from speaking with us; it conducted "in-depth interviews" with nearly two dozen staff, then distributed a public apology that two of them signed; it enlisted one of the most powerful law firms in the United States; it built multiple, high-production-value websites specifically designed to overcome the reputational damage that our reporting might cause."
Cygnet Healthcare
A UK subsidiary, Cygnet Health Care, was the subject of a BBC investigation that found that staff had been taunting, provoking and scaring vulnerable people. It runs 140 mental health services across the UK. 85% of its services are "rated good or outstanding by our regulators". New admissions were banned at Cygnet Acer clinic after the Care Quality Commission found it unsafe to use. A patient hanged herself, others self harmed, ligature points were found where patients could hang themselves and too many of the staff were untrained to deal with the highly vulnerable patients at the clinic.
The company bought four inpatient units which were previously operated by the Danshell Group in 2018. All four were condemned by the Care Quality Commission which raised concerns about patients' "unexplained injuries" and high levels of restraint in 2019.
Laurel Oaks Behavior Health Center
On February 8, 2024, a lawsuit was filed against the company's Dothan, Alabama-based Laurel Oaks Behavioral Health Center and its CEO Janette Jackson which alleged that Laurel Oaks Behavior Health Center mishandled numerous incidents involving the assault of an eight-year-old boy residing in the facility. The boy was reportedly assaulted by his larger roommate while he residing at the facility for a week in 2022. Universal Health Services would be sued as well. The lawsuit also noted that a 40-year-old man was convicted in 2011 of sexually assaulting a teenage patient while employed at Laurel Oaks. A 17-year-old patient had been charged in 2014 with felony counts of first-degree sodomy as well.
Provo Canyon School
Provo Canyon School was the name two residential treatment centers operated by UHS before being shutdown by the Utah DHHS. The school was in media headlines for years as abuse was prominent throughout its history, including past owners. To name a few allegations, "using a cruel, unusual, or unnecessary practice on a child by withholding personal interaction, emotional response, or stimulation", and "depriving [children] (cilents) of water, rest, and the opportunity for toileting."
Additional allegations
On May 16, 2021, Detroit Free Press published an article alleging UHS partner St. Simons By The Sea (formerly Focus By The Sea) in St. Simons Island, Georgia recruited patients from a local soup kitchen for treatment that may have been coercive or medically unnecessary.(subscription required)
Facilities
Hospitals and medical centers
As of June 2024, the UCS website lists the following medical and acute care facilities in the United States.
California
Corona
Southwest Healthcare Corona Regional Medical Center
Murrieta
A Plus Urgent Care
Southwest Healthcare Rancho Springs Hospital
Temecula Valley Day Surgery
Palmdale
Southwest Healthcare Palmdale Regional Medical Center
Riverside
Riverside Medical Clinic
Temecula
Southwest Healthcare Temecula Valley Hospital
Wildomar
Southwest Healthcare Inland Valley Hospital
District of Columbia
Washington
The George Washington University Hospital
Cedar Hill Hospital Medical Center
Florida
Arcadia
Manatee Diagnostic Center (Arcadia)
Bradenton
ER at Bayshore Gardens
ER at Sun City Center
ER at Palma Sola
Lakewood Ranch Medical Center
Lakewood Ranch Medical Group
Manatee Diagnostic Center (Pointe West)
Manatee Diagnostic Center (Riverside)
Manatee Health
Manatee Memorial Hospital
Manatee Physician Alliance
Orlando
University Behaviorial Center
Parrish
Manatee Diagnostic Center (Parrish)
Royal Palm Beach
Palms Westside Clinic ASC
Sarasota
ER at Fruitville
Wellington
Wellington Physicians Alliance
West Palm Beach
Wellington Regional Medical Center
Westlake
ER at Westlake
Wimauma
ER at Sun City Center
Nevada
Henderson
ER at Green Valley Ranch
Henderson Hospital
Las Vegas
Centennial Hills Hospital Medical Center
Elite Medical Center
ER at Blue Diamond
ER at Desert Springs
ER at West Craig Road
Spring Valley Hospital Medical Center
Summerlin Hospital Medical Center
Valley Health Physician Alliance
Valley Health Specialty Hospital
Valley Hospital Medical Center
North Las Vegas
ER at North Las Vegas
ER at Valley Vista
Pahrump
Desert View Hospital
Reno
ER at Damonte Ranch
ER at McCarran NW
Northern Nevada Sierra Medical Center
Quail Surgical and Pain Management Center
Sparks
ER at Spanish Springs
Northern Nevada Medical Center
Northern Nevada Medical Group
Oklahoma
Enid
St. Mary's Physician Associates
St. Mary's Regional Medical Center
Pennsylvania
King of Prussia
Eastern Pennsylvania Physician Alliance
UHS Corporate
South Carolina
Aiken
Aiken Physicians Alliance
Aiken Regional Medical Centers
Cancer Care Institute of Carolina
The Surgery Center of Aiken
North Augusta
ER at Sweetwater
Texas
Alamo
South Texas Health System ER Alamo
Amarillo
Northwest Emergency at Town Square
Northwest Emergency on Georgia
Northwest Physicians Group
Northwest Texas Healthcare System
Anna
ER at Anna
Bonham
TMC Bonham Hospital
Denison
Texoma Medical Center
TexomaCare
Eagle Pass
Fort Duncan Regional Medical Center
Edinburg
Cornerstone Regional Hospital
South Texas Health System Edinburg / South Texas Health System Children's
South Texas Health System ER McColl
South Texas Health System ER Monte Cristo
Laredo
Doctors Hospital Emergency Room Saunders
Doctors Hospital Emergency Room South
Doctors Hospital of Laredo
Laredo Physicians Group
McAllen
South Texas Health System Clinics
South Texas Health System ER Ware Road
South Texas Health System Heart
South Texas Health System McAllen
Mission
South Texas Health System ER Mission
Sherman
ER at Sherman
Weslaco
South Texas Health System ER Weslaco
Behavioral health facilities
UHS also operates over 300 behavioral health facilities in the United States and the United Kingdom, including:
Cygnet Health Care, UK
Psychiatric Institute of Washington, Washington, District of Columbia
Suncoast Behavioral Health Center, Bradenton, Florida
Fuller Hospital, South Attleboro, Massachusetts
Willow Springs Center, Reno, Nevada
Friends Hospital, Philadelphia, Pennsylvania
Provo Canyon School, Provo, Utah
Lancaster Behavioral Health Hospital, Lancaster, PA
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
| 指标 | 5年趋势 | UHS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 7.25年均值 ≈11.7 | ≈11.7 | 16.5 | 低估 | |
| PEG Ratio (市盈率增长比) | ≈0.4 | · | · | · |
同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | UHS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 11.4%5年均值 ≈10.1% | ≈10.1% | 11.9% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | 11.5%5年均值 ≈10.1% | ≈10.1% | 11.1% | 持平 | |
| 税前利润率 (TTM) | 11.2%5年均值 ≈9.1% | ≈9.1% | 9.8% | 持平 | |
| 净利润率 (TTM) | 8.4%5年均值 ≈6.9% | ≈6.9% | 7.3% | 持平 | |
| ROA (TTM) | 9.9%5年均值 ≈7.7% | ≈7.7% | 6.5% | 顶尖 | |
| ROE (TTM) | 21.0%5年均值 ≈17.0% | ≈17.0% | 19.1% | 持平 | |
| ROIC | 12.7%5年均值 ≈10.8% | ≈10.8% | 13.5% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | UHS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.65年均值 ≈0.7 | ≈0.7 | 0.2 | 高负债 | |
| 流动比率 (MRQ) | 1.15年均值 ≈1.2 | ≈1.2 | 1.2 | 低流动性 | |
| Quick Ratio (速动比率) | 0.85年均值 ≈1.0 | ≈1.0 | 0.9 | 持平 | |
| 长期负债/股东权益 (MRQ) | 0.55年均值 ≈0.7 | ≈0.7 | 0.2 | 高负债 | |
| Interest Coverage (利息保障倍数) | 12.85年均值 ≈9.2 | ≈9.2 | 7.8 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | UHS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 9.7%5年均值 ≈9.0% | ≈9.0% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 9.0%5年均值 ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 8.5% | · | · | · | |
| EPS YoY | 37.3%5年均值 ≈37.9% | ≈37.9% | · | · | |
| Net Income YoY (净利润同比增长) | 30.4%5年均值 ≈31.9% | ≈31.9% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率(3年)) | 36.2%5年均值 ≈15.4% | ≈15.4% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率(5年)) | 16.0% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率(3年)) | 30.1%5年均值 ≈8.7% | ≈8.7% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率(5年)) | 9.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | UHS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 1.25年均值 ≈1.1 | ≈1.1 | 0.8 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 7.35年均值 ≈7.0 | ≈7.0 | 8.4 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数(报告的 headcount,yfinance)。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$170.2K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 | 货币 | 收益率 |
|---|---|---|---|
| 九月 1, 2026 | $0.20 | USD | ≈0.47% |
| 六月 8, 2026 | $0.20 | USD | ≈0.56% |
| 三月 2, 2026 | $0.20 | USD | ≈0.39% |
| 十二月 1, 2025 | $0.20 | USD | ≈0.33% |
| 九月 2, 2025 | $0.20 | USD | ≈0.44% |
| 六月 2, 2025 | $0.20 | USD | ≈0.43% |
| 三月 3, 2025 | $0.20 | USD | ≈0.46% |
| 十二月 3, 2024 | $0.20 | USD | ≈0.40% |
| 九月 3, 2024 | $0.20 | USD | ≈0.34% |
| 六月 3, 2024 | $0.20 | USD | ≈0.43% |
| 二月 29, 2024 | $0.20 | USD | ≈0.48% |
| 十一月 30, 2023 | $0.20 | USD | ≈0.58% |
| 八月 31, 2023 | $0.20 | USD | ≈0.59% |
| 五月 31, 2023 | $0.20 | USD | ≈0.61% |
| 二月 28, 2023 | $0.20 | USD | ≈0.60% |
| 十一月 30, 2022 | $0.20 | USD | ≈0.61% |
| 八月 31, 2022 | $0.20 | USD | ≈0.82% |
| 五月 31, 2022 | $0.20 | USD | ≈0.64% |
| 二月 28, 2022 | $0.20 | USD | ≈0.56% |
| 十一月 30, 2021 | $0.20 | USD | ≈0.67% |
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 七月 27, 2026 | $5.98 | $6.02 | -0.61% |
| 2026年3月31日 | $5.62 | $5.46 | 2.9% | |
| 2025年12月31日 | $5.88 | $5.96 | -1.3% | |
| 2025年9月30日 | $5.69 | $4.88 | 16.5% | |
| 2025年6月30日 | $5.35 | $4.97 | 7.6% | |
| 2025年3月31日 | $4.84 | $4.39 | 10.2% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Operating Expenses | $15.37B | $14.15B | $13.11B | $12.40B | $11.28B | $10.20B | $10.16B | $9.60B | $9.13B | $8.48B | $7.78B | $7.14B | |
| Operating Income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.26B | $1.06B | |
| Interest Expense | $156M | $186M | $207M | $127M | $84M | $106M | $163M | $155M | $145M | $125M | $113M | $134M | |
| Other Non-op | $134M | $2M | $-28M | $-10M | $14M | $14.0K | $13M | $14M | $0 | $0 | · | · | |
| Pretax Income | $1.97B | $1.50B | $940M | $866M | $1.29B | $1.25B | $1.07B | $1.03B | $1.14B | $1.16B | $1.15B | $930M | |
| Income Tax | $461M | $335M | $221M | $209M | $306M | $299M | $239M | $237M | $364M | $409M | $395M | $325M | |
| Net Income | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| EPS (Basic) | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 | $9.16 | $8.35 | $7.86 | $7.22 | $6.89 | $5.52 | |
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 | |
| Shares (Basic) | 63,581,000 | 66,554,000 | 69,321,000 | 73,118,000 | 82,519,000 | 85,061,000 | 88,762,000 | 93,276,000 | 95,652,000 | 97,208,000 | 98,797,000 | 98,826,000 | |
| Shares (Diluted) | 64,462,000 | 67,896,000 | 70,125,000 | 73,832,000 | 83,692,000 | 85,587,000 | 89,040,000 | 93,750,000 | 96,325,000 | 98,380,000 | 100,694,000 | 100,544,000 | |
| EBITDA | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.66B | $1.44B |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $138M | $126M | $119M | $103M | $115M | $1.22B | $61M | $105M | $74M | $34M | $61M | $32M | |
| Receivables | $2.60B | $2.18B | $2.24B | $2.02B | $1.75B | $1.73B | $1.56B | $1.51B | $1.50B | $1.44B | $1.30B | $1.28B | |
| Other Current Assets | $436M | $292M | $237M | $198M | $195M | $138M | $134M | $174M | $87M | $83M | $103M | $78M | |
| Current Assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B | $3.28B | $1.92B | $1.94B | $1.80B | $1.68B | $1.72B | $1.62B | |
| PP&E (Net) | $7.01B | $6.57B | $6.12B | $5.92B | $5.87B | $5.37B | $5.02B | $4.85B | $4.57B | $4.33B | $3.84B | $3.68B | |
| PP&E (Gross) | $13.49B | $12.64B | $11.78B | $11.09B | $10.77B | $9.89B | $9.11B | $8.56B | $7.92B | $7.31B | $6.53B | $6.21B | |
| Accum. Depreciation | $6.48B | $6.07B | $5.65B | $5.17B | $4.90B | $4.51B | $4.09B | $3.72B | $3.35B | $2.98B | $2.69B | $2.53B | |
| Goodwill | $3.99B | $3.93B | $3.93B | $3.91B | $3.96B | $3.88B | $3.87B | $3.84B | $3.83B | $3.78B | $3.60B | $3.29B | |
| Intangibles | $76M | $76M | $77M | $78M | $81M | $83M | $84M | $173M | $220M | $228M | $219M | $98M | |
| Other Non-current Assets | $5.11B | $5.08B | $5.03B | $5.04B | $4.96B | $4.82B | $4.74B | $4.48B | $4.39B | $4.31B | $4.06B | $3.68B | |
| Total Assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.95B | |
| Accounts Payable | $750M | $632M | $614M | $637M | $659M | $571M | $447M | $446M | $442M | $440M | $366M | $336M | |
| Current Liabilities | $3.24B | $2.21B | $2.01B | $1.91B | $1.98B | $2.48B | $1.56B | $1.45B | $1.85B | $1.32B | $1.10B | $1.18B | |
| Capital Leases | $341M | $376M | $383M | $396M | $305M | $278M | $270M | $18M | $20M | $22M | $23M | · | |
| Deferred Tax | $6M | $0 | · | · | $0 | $6M | $25M | $50M | $55M | $88M | $316M | $168M | |
| Other Non-current Liabilities | $528M | $656M | $584M | $488M | $465M | $459M | $330M | $362M | $306M | $275M | $279M | $269M | |
| Long-term Debt | $4.80B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.43B | $3.28B | |
| Total Debt | $4.75B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.45B | $3.28B | |
| Retained Earnings | $7.99B | $7.37B | $6.80B | $6.53B | $6.60B | $6.75B | $5.93B | $5.79B | $5.35B | $4.89B | $4.57B | $4.02B | |
| AOCI | $48M | $7M | $9M | $-10M | $30M | $48M | $32M | $4M | $7M | $-25M | $-23M | $-25M | |
| Stockholders' Equity | $7.28B | $6.67B | $6.15B | $5.92B | $6.09B | $6.32B | $5.50B | $5.39B | $4.99B | $4.53B | $4.25B | $3.74B | |
| Liabilities + Equity | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.97B |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $619M | $585M | $568M | $582M | $533M | $510M | $490M | $453M | $448M | $417M | $399M | $376M | |
| Stock-based Comp | $96M | $99M | $88M | $85M | $74M | $66M | $69M | $67M | $57M | $48M | $40M | $31M | |
| Deferred Tax | $51M | $-33M | $-18M | $-18M | $-30M | $-27M | $-36M | $-10M | $-37M | $-10M | $-11M | $49M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | $-88M | $35M | |
| Operating Cash Flow | $1.86B | $2.07B | $1.27B | $996M | $884M | $2.36B | $1.44B | $1.27B | $1.25B | $1.33B | $1.07B | $1.04B | |
| CapEx | $1.02B | $944M | $743M | $734M | $856M | $731M | $634M | $665M | $558M | $520M | $379M | $391M | |
| Investing Cash Flow | $-1.07B | $-911M | $-763M | $-647M | $-914M | $-803M | $-688M | $-747M | $-685M | $-1.16B | $-913M | $-833M | |
| Net Debt Issued | $-44M | $-2.64B | $-85M | $-89M | $-3.04B | $-963M | $-57M | $-830M | $-143M | $-459M | $-68M | $-879M | |
| Stock Issued | $17M | $15M | $14M | $14M | $13M | $12M | $11M | $10M | $10M | $10M | $8M | $7M | |
| Stock Repurchased | $968M | $671M | $547M | $833M | $1.22B | $207M | $771M | $397M | $364M | $353M | $210M | $101M | |
| Net Stock Activity | $-951M | $-656M | $-534M | $-819M | $-1.21B | $-194M | $-760M | $-387M | $-354M | $-344M | $-201M | $-94M | |
| Dividends Paid | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M | |
| Financing Cash Flow | $-750M | $-1.14B | $-494M | $-318M | $-1.07B | $-385M | $-845M | $-492M | $-519M | $-171M | $-125M | $-187M | |
| Net Change in Cash | $47M | $10M | $14M | $22M | $-1.10B | $1.17B | $-94M | $32M | $45M | $5M | $29M | $15M | |
| Taxes Paid | $471M | $325M | $258M | $251M | $363M | $286M | $261M | $294M | $371M | $345M | $381M | $259M | |
| Free Cash Flow | $849M | $1.12B | $525M | $262M | $28M | $1.63B | $804M | $676M | $625M | $769M | $642M | $645M | |
| Levered FCF | $730M | $979M | $367M | $166M | $-36M | $1.55B | $678M | $556M | $526M | $688M | $567M | $558M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 13.9% | 13.2% | |
| Net Margin | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% | 7.5% | 6.8% | |
| Pretax Margin | 11.4% | 9.5% | 6.6% | 6.5% | 10.2% | 10.8% | 9.4% | 9.6% | 10.9% | 11.8% | 12.7% | 11.5% | |
| EBITDA Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 18.3% | 17.8% | |
| ROA | 9.9% | 8.0% | 5.2% | 5.0% | 7.6% | 7.1% | 7.0% | 6.9% | 7.0% | 7.0% | 7.2% | 6.1% | |
| ROE | 21.4% | 17.8% | 11.9% | 11.2% | 16.0% | 16.0% | 15.0% | 15.0% | 15.8% | 16.0% | 17.0% | 15.6% | |
| ROIC | 12.7% | 11.7% | 8.1% | 7.1% | 10.1% | 10.2% | 10.0% | 9.7% | 9.6% | 9.6% | 10.7% | 9.9% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.3 | 1.4 | 1.3 | 1.1 | 1.3 | 1.2 | 1.3 | 1.0 | 1.3 | 1.6 | 1.4 | |
| Quick Ratio | 0.8 | 1.0 | 1.2 | 1.1 | 0.9 | 1.2 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 1.1 | |
| Debt / Equity | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.9 | 0.8 | 0.9 | |
| Interest Coverage | 12.8 | 9.0 | 5.7 | 7.9 | 16.3 | 12.8 | 7.5 | 7.6 | 8.8 | 10.2 | 11.1 | 8.0 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.0 | 1.0 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | |
| Receivables Turnover | 7.3 | 7.2 | 6.7 | 7.1 | 7.3 | 7.0 | 7.4 | 7.2 | 7.1 | 7.1 | 7.0 | 6.7 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $269.38 | $233.12 | $203.66 | $181.48 | $151.06 | $135.05 | $127.79 | $114.90 | $108.07 | $99.27 | $89.81 | $80.22 | |
| Cash Flow / Share | $28.92 | $30.45 | $18.08 | $13.49 | $10.56 | $27.58 | $16.16 | $14.30 | $12.28 | $13.10 | $10.14 | $10.30 | |
| Dividend Paid / Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | · | $0.60 | $0.40 | · | · | · | $0.30 | |
| EPS (TTM) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.7% | 10.8% | 6.6% | 6.0% | 9.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.0% | 7.8% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 37.3% | 64.4% | 11.9% | -22.7% | 7.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.2% | 12.5% | -2.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 16.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 30.4% | 59.1% | 6.2% | -31.9% | 5.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 30.1% | 4.8% | -8.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 24.2% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Net Income TTM | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| P/E | 9.4 | 10.7 | 14.9 | 15.4 | 11.0 | 12.5 | 15.7 | 14.0 | 14.5 | 14.9 | 17.7 | 20.5 | |
| Earnings Yield | 10.6% | 9.4% | 6.7% | 6.5% | 9.1% | 8.0% | 6.4% | 7.1% | 6.9% | 6.7% | 5.7% | 4.9% | |
| Payout Ratio | 3.4% | 4.7% | 7.7% | 8.6% | 6.7% | 1.8% | 6.5% | 4.8% | 5.1% | 5.5% | 5.8% | 5.4% | |
| Annual Payout | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B | $3.56B | $3.55B | $3.47B | $3.45B | $3.34B | |
| Operating Expenses | $4.12B | $3.99B | $3.97B | $3.97B | $3.78B | $3.64B | $3.64B | $3.58B | $3.47B | $3.45B | $3.37B | $3.28B | $3.27B | $3.19B | $3.19B | $3.06B | |
| Operating Income | $517M | $503M | $517M | $522M | $500M | $455M | $472M | $384M | $436M | $389M | $331M | $285M | $280M | $279M | $261M | $276M | |
| Interest Expense | $40M | $37M | $42M | $38M | $35M | $40M | $40M | $45M | $49M | $53M | $54M | $53M | $49M | $51M | $44M | $36M | |
| Other Non-op | $2M | $3M | $106M | $14M | $8M | $6M | $6M | $2M | $-5M | $150.0K | $4M | $-11M | $-7M | $-14M | $5M | $-6M | |
| Pretax Income | $479M | $469M | $581M | $497M | $473M | $420M | $438M | $342M | $382M | $336M | $281M | $221M | $225M | $214M | $222M | $234M | |
| Income Tax | $115M | $110M | $134M | $118M | $111M | $99M | $101M | $76M | $88M | $70M | $62M | $52M | $55M | $52M | $52M | $57M | |
| Net Income | $358M | $349M | $446M | $373M | $353M | $317M | $332M | $259M | $289M | $262M | $216M | $167M | $171M | $163M | $175M | $183M | |
| EPS (Basic) | $6.01 | $5.71 | $7.14 | $5.92 | $5.49 | $4.87 | $5.05 | $3.89 | $4.32 | $3.90 | $3.18 | $2.42 | $2.44 | $2.31 | $2.44 | $2.52 | |
| EPS (Diluted) | $5.98 | $5.65 | $7.01 | $5.86 | $5.43 | $4.80 | $4.94 | $3.80 | $4.26 | $3.82 | $3.13 | $2.40 | $2.42 | $2.28 | $2.42 | $2.50 | |
| Shares (Basic) | 59,657,000 | 61,071,000 | · | 62,974,000 | 64,356,000 | 64,970,000 | · | 66,537,000 | 66,878,000 | 67,204,000 | · | 68,867,000 | 70,073,000 | 70,535,000 | · | 72,595,000 | |
| Shares (Diluted) | 59,910,000 | 61,668,000 | · | 63,663,000 | 64,991,000 | 66,037,000 | · | 68,108,000 | 67,920,000 | 68,482,000 | · | 69,624,000 | 70,839,000 | 71,487,000 | · | 73,060,000 | |
| EBITDA | $517M | $503M | · | $522M | $500M | $455M | · | $384M | $436M | $389M | · | $285M | $280M | $279M | · | $276M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $119M | $138M | $113M | $138M | $127M | $126M | $106M | $129M | $112M | $119M | $81M | $79M | $110M | $103M | $75M | |
| Receivables | $2.80B | $2.75B | $2.60B | $2.59B | $2.30B | $2.41B | $2.18B | $2.21B | $2.16B | $2.30B | · | $2.23B | $2.10B | $2.03B | · | $1.90B | |
| Other Current Assets | $505M | $406M | $436M | $333M | $327M | $317M | $292M | $262M | $236M | $243M | · | $223M | $226M | $201M | · | $262M | |
| Current Assets | $3.68B | $3.50B | $3.41B | $3.26B | $2.99B | $3.08B | $2.82B | $2.80B | $2.74B | $2.87B | · | $2.75B | $2.62B | $2.56B | · | $2.46B | |
| PP&E (Net) | $7.14B | $7.06B | $7.01B | $6.97B | $6.88B | $6.70B | $6.57B | $6.44B | $6.33B | $6.18B | · | $6.09B | $6.03B | $5.95B | · | $5.94B | |
| PP&E (Gross) | $13.83B | $13.61B | · | $13.45B | $13.24B | $12.91B | · | $12.45B | $12.24B | $11.96B | · | $11.61B | $11.44B | $11.25B | · | $11.10B | |
| Accum. Depreciation | $6.69B | $6.55B | $6.48B | $6.48B | $6.35B | $6.21B | $6.07B | $6.01B | $5.91B | $5.77B | · | $5.52B | $5.41B | $5.30B | · | $5.17B | |
| Goodwill | $3.98B | $3.98B | $3.99B | $3.99B | $3.98B | $3.95B | $3.93B | $3.97B | $3.94B | $3.93B | $3.93B | $3.91B | $3.93B | $3.91B | $3.91B | $3.87B | |
| Intangibles | · | · | $76M | · | · | · | $76M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $5.11B | · | · | · | $5.08B | · | · | · | · | · | · | · | · | · | |
| Total Assets | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B | |
| Accounts Payable | · | · | $750M | · | · | · | $632M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.30B | $3.24B | $3.24B | $3.16B | $2.32B | $2.33B | $2.21B | $2.01B | $2.15B | $2.08B | · | $1.99B | $2.04B | $1.86B | · | $1.94B | |
| Capital Leases | $339M | $345M | $341M | $346M | $352M | $369M | $376M | $378M | $380M | $374M | · | $389M | $388M | $396M | · | $393M | |
| Deferred Tax | $3M | $3M | $6M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $560M | $533M | $528M | $590M | $629M | $682M | $656M | $660M | $570M | $551M | · | $588M | $571M | $532M | · | $500M | |
| Long-term Debt | $4.90B | $4.70B | $4.75B | $4.70B | $4.60B | $4.60B | $4.50B | $4.70B | $4.50B | $4.90B | · | $4.90B | $4.70B | $4.80B | · | $4.70B | |
| Total Debt | $4.85B | $4.71B | · | $4.69B | $4.58B | $4.65B | · | $4.66B | $4.54B | $4.86B | · | $4.92B | $4.72B | $4.80B | · | $4.70B | |
| Retained Earnings | · | · | $7.99B | · | · | · | $7.37B | · | · | · | · | · | · | · | · | · | |
| AOCI | · | · | $48M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $7.51B | $7.46B | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B | $6.61B | $6.49B | $6.26B | · | $6.06B | $6.09B | $6.01B | · | $5.86B | |
| Liabilities + Equity | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $167M | $155M | $163M | $155M | $152M | $148M | $147M | $150M | $147M | $141M | $145M | $137M | $144M | $142M | $148M | $146M | |
| Stock-based Comp | $23M | $23M | $25M | $25M | $24M | $22M | $27M | $27M | $27M | $20M | $22M | $23M | $22M | $21M | $23M | $21M | |
| Operating Cash Flow | $443M | $402M | $575M | $381M | $549M | $360M | $658M | $333M | $679M | $396M | $452M | $162M | $363M | $291M | $297M | $221M | |
| CapEx | $228M | $217M | $281M | $229M | $266M | $239M | $246M | $248M | $241M | $209M | $206M | $200M | $168M | $169M | $164M | $162M | |
| Investing Cash Flow | $-234M | $-198M | $-224M | $-269M | $-306M | $-271M | $-208M | $-266M | $-243M | $-195M | $-239M | $-176M | $-170M | $-178M | $-248M | $-73M | |
| Net Debt Issued | · | $-45M | · | · | · | $-9M | · | · | · | $-64M | · | · | · | $-16M | · | · | |
| Stock Issued | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $4M | $4M | |
| Stock Repurchased | $321M | $164M | $352M | $237M | $155M | $223M | $250M | $183M | $96M | $142M | $162M | $176M | $125M | $85M | $110M | $158M | |
| Net Stock Activity | · | $-160M | · | · | · | $-220M | · | · | · | $-139M | · | · | · | $-82M | · | · | |
| Dividends Paid | $12M | $13M | $12M | $12M | $13M | $14M | $13M | $13M | $13M | $14M | $14M | $14M | $14M | $14M | $14M | $15M | |
| Financing Cash Flow | $-189M | $-222M | $-296M | $-135M | $-228M | $-91M | $-427M | $-90M | $-420M | $-209M | $-182M | $18M | $-224M | $-106M | $-15M | $-179M | |
| Net Change in Cash | $20M | $-19M | $55M | $-25M | $18M | $-1M | $20M | $-19M | $17M | $-8M | $34M | $1M | $-30M | $8M | $35M | $-37M | |
| Taxes Paid | $189M | $8M | $115M | $104M | $246M | $6M | $88M | $105M | $129M | $3M | $67M | $57M | $131M | $2M | $69M | $37M | |
| Free Cash Flow | · | $184M | · | · | · | $121M | · | · | · | $188M | · | · | · | $122M | · | · | |
| Levered FCF | · | $156M | · | · | · | $90M | · | · | · | $146M | · | · | · | $83M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| Net Margin | 7.7% | 7.8% | · | 8.3% | 8.2% | 7.7% | · | 6.5% | 7.4% | 6.8% | · | 4.7% | 4.8% | 4.7% | · | 5.5% | |
| Pretax Margin | 10.3% | 10.4% | · | 11.1% | 11.1% | 10.3% | · | 8.6% | 9.8% | 8.7% | · | 6.2% | 6.3% | 6.2% | · | 7.0% | |
| EBITDA Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| ROA | 2.3% | 2.3% | · | 2.5% | 2.4% | 2.2% | · | 1.8% | 2.1% | 1.9% | · | 1.2% | 1.3% | 1.2% | · | 1.4% | |
| ROE | 4.9% | 4.9% | · | 5.4% | 5.2% | 4.9% | · | 4.1% | 4.6% | 4.3% | · | 2.8% | 2.9% | 2.8% | · | 3.0% | |
| ROIC | 3.2% | 3.2% | · | 3.4% | 3.3% | 3.0% | · | 2.7% | 3.0% | 2.8% | · | 2.0% | 1.9% | 1.9% | · | 2.0% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.0 | 1.3 | 1.3 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 12.9 | 13.5 | · | 13.6 | 14.1 | 11.4 | · | 8.6 | 8.9 | 7.4 | · | 5.3 | 5.7 | 5.5 | · | 7.7 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.9 | 1.7 | · | 1.8 | 1.8 | 1.8 | · | 1.7 | 1.8 | 1.8 | · | 1.8 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $77.42 | $72.89 | · | $70.61 | $65.91 | $62.08 | · | $58.19 | $57.53 | $56.13 | · | $51.17 | $50.09 | $48.51 | · | $45.66 | |
| Cash Flow / Share | · | $6.51 | · | · | · | $5.45 | · | · | · | $5.79 | · | · | · | $4.07 | · | · | |
| Dividend Paid / Share | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | |
| EPS (TTM) | $24.50 | $23.95 | · | $21.03 | $18.97 | $17.80 | · | $15.01 | $13.61 | $11.77 | · | $9.52 | $9.62 | $9.40 | · | $9.72 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18.11B | $17.76B | · | $16.99B | $16.46B | $16.08B | · | $15.42B | $15.02B | $14.66B | · | $14.03B | $13.80B | $13.57B | · | $13.23B | |
| Net Income TTM | $1.53B | $1.52B | · | $1.38B | $1.26B | $1.20B | · | $1.03B | $934M | $817M | · | $676M | $692M | $685M | · | $740M | |
| P/E | 6.1 | 7.5 | · | 9.7 | 9.5 | 10.6 | · | 15.3 | 13.6 | 15.5 | · | 13.2 | 16.4 | 13.5 | · | 9.1 | |
| Earnings Yield | 16.5% | 13.4% | · | 10.3% | 10.5% | 9.5% | · | 6.6% | 7.4% | 6.5% | · | 7.6% | 6.1% | 7.4% | · | 11.0% | |
| Payout Ratio | · | 3.7% | · | · | · | 4.3% | · | · | · | 5.2% | · | · | · | 8.7% | · | · | |
| Annual Payout | $50M | $51M | · | $52M | $53M | $53M | · | $54M | $54M | $55M | · | $56M | $57M | $58M | · | $60M |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| 收入 | $17.36B | $15.83B | $14.28B | · | · |
| 营业利润率 % | 11.5% | 10.6% | 8.2% | · | · |
| 净收入 | $1.49B | $1.14B | $718M | · | · |
| 稀释后每股收益 (EPS) | $23.10 | $16.82 | $10.23 | · | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.7 | 0.7 | 0.8 | · | · |
| 流动比率 | 1.1 | 1.3 | 1.4 | · | · |
| 速动比率 | 0.8 | 1.0 | 1.2 | · | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| 自由现金流 | $849M | $1.12B | $525M | · | · |
机构持有人 (13F) 642 家申报者 · $9.0B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 73 (-10 与上一季度对比) | 122 (+33 与上一季度对比) | 215 (-37 与上一季度对比) | 240 (+8 与上一季度对比) | +2.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1414195886 | 6486542 | 15.65% | 股份 |
| First Eagle Investment Management, LLC | $677233918 | 4554670 | 7.49% | 股份 |
| BlackRock, Inc. | $603655463 | 4059826 | 6.68% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $504386069 | 3392199 | 5.58% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $364614198 | 2452177 | 4.03% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $328686665 | 2210595 | 3.64% | 股份 |
| STATE STREET CORP | $312637527 | 2102613 | 3.46% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $293152556 | 1974065 | 3.24% | 股份 |
| PZENA INVESTMENT MANAGEMENT LLC | $292819232 | 1969327 | 3.24% | 股份 |
| Invesco Ltd. | $290116048 | 1951147 | 3.21% | 股份 |
| FMR LLC | $210657318 | 1416755 | 2.33% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $210522439 | 1415848 | 2.33% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $158819352 | 1068124 | 1.76% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $140451548 | 944592 | 1.55% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $135479763 | 906103 | 1.50% | 股份 |
| NORGES BANK | $132110916 | 888499 | 1.46% | 股份 |
| MORGAN STANLEY | $111481141 | 749754 | 1.23% | 股份 |
| GOLDMAN SACHS GROUP INC | $89504438 | 601953 | 0.99% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $85524258 | 575185 | 0.95% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $83716782 | 563029 | 0.93% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $76891019 | 523210 | 0.85% | 股份 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $75911300 | 510534 | 0.84% | 股份 |
| NORTHERN TRUST CORP | $67032574 | 450821 | 0.74% | 股份 |
| Invenomic Capital Management LP | $63529884 | 427264 | 0.70% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $62058597 | 417369 | 0.69% | 股份 |
| Qube Research & Technologies Ltd | $59094313 | 397433 | 0.65% | 股份 |
| MACKENZIE FINANCIAL CORP | $56636764 | 380905 | 0.63% | 股份 |
| Ranmore Fund Management Ltd | $56501159 | 379993 | 0.63% | 股份 |
| Allianz Asset Management GmbH | $56202738 | 377986 | 0.62% | 股份 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $52580501 | 353625 | 0.58% | 股份 |
| UBS Group AG | $49695321 | 334221 | 0.55% | 股份 |
| CITADEL ADVISORS LLC | $45818377 | 308147 | 0.51% | 股份 |
| Quantinno Capital Management LP | $45782797 | 307907 | 0.51% | 股份 |
| Bank of New York Mellon Corp | $44605741 | 299992 | 0.49% | 股份 |
| NORDEA INVESTMENT MANAGEMENT AB | $44371846 | 300663 | 0.49% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $44081678 | 296467 | 0.49% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42437187 | 237119 | 0.47% | 股份 |
| Khrom Capital Management LLC | $39401958 | 264994 | 0.44% | 股份 |
| Russell Investments Group, Ltd. | $37642835 | 253289 | 0.42% | 股份 |
| Bridgewater Associates, LP | $33919311 | 228121 | 0.38% | 股份 |
| SEI INVESTMENTS CO | $33100670 | 222614 | 0.37% | 股份 |
| MOORE CAPITAL MANAGEMENT, LP | $33071927 | 222422 | 0.37% | 股份 |
| Allspring Global Investments Holdings, LLC | $32949468 | 218817 | 0.36% | 股份 |
| DEUTSCHE BANK AG\ | $31202151 | 209847 | 0.35% | 股份 |
| FIRST TRUST ADVISORS LP | $31057609 | 208876 | 0.34% | 股份 |
| CARRONADE CAPITAL MANAGEMENT, LP | $29738000 | 200000 | 0.33% | 股份 |
| JPMORGAN CHASE & CO | $29603947 | 198975 | 0.33% | 股份 |
| Arbejdsmarkedets Tillaegspension | $28712039 | 193100 | 0.32% | 股份 |
| FRANKLIN RESOURCES INC | $28049718 | 188646 | 0.31% | 股份 |
| BARCLAYS PLC | $27758340 | 186686 | 0.31% | 股份 |
公司内部人士 24 位内幕人士 · 10 位高管 · 16 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Marc D Miller | President and CEO | 2026年3月26日 A | 388621 | 0 | 0 | $0 |
| Steve Filton | Executive Vice President & CFO | 2026年3月26日 A | 144715 | 0 | 0 | $0 |
| Alan B Miller | Executive Chairman | 2026年5月27日 J | 25495 | 0 | 0 | $0 |
| Edward H Sim | Executive Vice President | 2026年3月26日 A | 24790 | 0 | 0 | $0 |
| Matthew Jay Peterson | Executive Vice President, UHS | 2026年3月26日 A | 31984 | 0 | 0 | $0 |
| Marvin G. Pember | Executive Vice President | 2022年3月23日 A | 36599 | 0 | 0 | $0 |
| Debra K Osteen | Executive Vice President | 2018年4月13日 A | 93174 | 0 | 0 | $0 |
| Richard C Wright | Vice President | 2012年11月26日 S | 0 | 0 | 0 | $0 |
| Michael Marquez | Senior Vice President | 2010年6月4日 M | 28525 | 0 | 0 | $0 |
| Kevin J Gross | Senior Vice President | 2007年5月31日 M | 623 | 0 | 0 | $0 |
| Nina Chen-Langenmayr | 董事 | 2026年5月20日 A | 4267 | 0 | 0 | $0 |
| Maria Ruderman Singer | 董事 | 2026年5月20日 A | 9792 | 0 | 0 | $0 |
| Warren J. Nimetz | 董事 | 2026年5月20日 A | 9698 | 0 | 2 | $-852356 |
| Eileen C. Mcdonnell | 董事 | 2026年5月20日 A | 9406 | 0 | 0 | $0 |
| Elliot J Md Mba Sussman | 董事 | 2026年5月20日 A | 7330 | 0 | 3 | $-345899 |
| Lawrence S. Gibbs | 董事 | 2023年3月7日 S | 2230 | 0 | 0 | $0 |
| Robert H Hotz | 董事 | 2019年7月29日 M | 52715 | 0 | 0 | $0 |
| John H Herrell | 董事 | 2018年5月15日 M | 19274 | 0 | 0 | $0 |
| Anthony Pantaleoni | 董事 | 2017年11月29日 M | 1794 | 0 | 0 | $0 |
| Leatrice Ducat | 董事 | 2013年3月5日 M | 4000 | 0 | 0 | $0 |
| Richard J Santorum | 董事 | 2011年5月16日 M | 7437 | 0 | 0 | $0 |
| Daniel B. Silvers | 董事 | 2011年5月3日 M | 2048 | 0 | 0 | $0 |
| John F Williams JR | 董事 | 2008年11月21日 A | 3975 | 0 | 0 | $0 |
| Robert A Meister | 董事 | 2007年11月21日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
ETF持仓 由 104 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded Alpha... | 2.57% | 159598 NS | 2026年7月31日 | N-PORT |
| LYLD · Cambria ETF Trust | 2.14% | 922 NS | 2026年7月31日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.62% | 81159 SH | 2026年10月1日 | 每日 |
| CVSM · Elevation Series Trust | 1.59% | 8938 NS | 2026年7月31日 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.51% | 176878 SH | 2026年10月1日 | 每日 |
| IHF · iShares Trust | 1.35% | 102351 SH | 2026年9月11日 | 每日 |
| RNIN · EA Series Trust | 1.29% | 13918 NS | 2026年7月31日 | N-PORT |
| SYLD · Cambria ETF Trust | 1.09% | 64307 NS | 2026年7月31日 | N-PORT |
| SRHQ · Elevation Series Trust | 1.04% | 13049 NS | 2026年7月31日 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 0.95% | 15263 NS | 2026年7月31日 | N-PORT |
| FNK · First Trust Exchange-Traded Alpha... | 0.80% | 10896 NS | 2026年7月31日 | N-PORT |
| FDRR · FIDELITY COVINGTON TRUST | 0.54% | 23720 NS | 2026年7月31日 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.49% | 43874 NS | 2026年7月31日 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.44% | 41492 SH | 2026年10月1日 | 每日 |
| FNX · First Trust Exchange-Traded Alpha... | 0.42% | 34637 NS | 2026年7月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.40% | 345907 NS | 2026年7月31日 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.31% | 29932 SH | 2026年10月1日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.31% | 151188 NS | 2026年7月31日 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund ... | 0.28% | 7534 NS | 2026年7月31日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.27% | 7517 NS | 2026年7月31日 | N-PORT |
| FAB · First Trust Exchange-Traded Alpha... | 0.24% | 2408 NS | 2026年7月31日 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 1112873 SH | 2026年10月1日 | 每日 |
| BKMC · BNY Mellon ETF Trust | 0.20% | 7667 NS | 2026年7月31日 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Inde... | 0.19% | 5968000 | 2026年10月1日 | 每日 |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.19% | 22463 NS | 2026年7月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 27092 NS | 2026年7月31日 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0.18% | 107089 NS | 2026年7月31日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.16% | 737146 SH | 2026年8月19日 | 每日 |
| PFIG · Invesco Exchange-Traded Fund Trus... | 0.16% | 220000 | 2026年10月1日 | 每日 |
| JVAL · J.P. Morgan Exchange-Traded Fund ... | 0.15% | 7588 NS | 2026年7月31日 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.15% | 8469 SH | 2026年8月19日 | 每日 |
| IYH · iShares Trust | 0.14% | 29765 SH | 2026年9月11日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 24277 NS | 2026年7月31日 | N-PORT |
| SMMD · iShares Trust | 0.12% | 27226 SH | 2026年9月11日 | 每日 |
| LGDX · Tidal Trust III | 0.12% | 1016 NS | 2026年7月31日 | N-PORT |
| IXJ · iShares Trust | 0.12% | 28234 SH | 2026年9月11日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.12% | 105486 NS | 2026年7月31日 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Inde... | 0.11% | 3422000 | 2026年9月30日 | 每日 |
| NFRA · FlexShares Trust | 0.11% | 20262 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.11% | 153595 SH | 2026年8月19日 | 每日 |
| GLOF · iShares Trust | 0.11% | 1247 SH | 2026年9月11日 | 每日 |
| CURE · Direxion Shares ETF Trust | 0.10% | 1049 NS | 2026年7月31日 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.10% | 4369 SH | 2026年10月1日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.09% | 3027 NS | 2026年7月31日 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trus... | 0.09% | 51375 SH | 2026年10月1日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.09% | 1161113 SH | 2026年8月19日 | 每日 |
| IWS · iShares Trust | 0.09% | 75629 SH | 2026年9月11日 | 每日 |
| WSML · iShares Trust | 0.08% | 3240 SH | 2026年9月11日 | 每日 |
| TILT · FlexShares Trust | 0.08% | 9796 NS | 2026年7月31日 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Inde... | 0.07% | 4075 SH | 2026年10月1日 | 每日 |
| RECS · Columbia ETF Trust I | 0.07% | 25532 NS | 2026年7月31日 | N-PORT |
| IWR · iShares Trust | 0.06% | 208577 SH | 2026年9月11日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.06% | 53251 NS | 2026年7月31日 | N-PORT |
| XOEF · iShares Trust | 0.05% | 67 SH | 2026年9月11日 | 每日 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.05% | 28658 SH | 2026年10月1日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.04% | 107516 NS | 2026年7月31日 | N-PORT |
| IVE · iShares Trust | 0.03% | 88425 SH | 2026年9月11日 | 每日 |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.03% | 12323 SH | 2026年8月19日 | 每日 |
| IUSV · iShares Trust | 0.03% | 46100 SH | 2026年9月11日 | 每日 |
| DCOR · Dimensional ETF Trust | 0.03% | 5685 NS | 2026年7月31日 | N-PORT |
| IWD · iShares Trust | 0.02% | 112974 SH | 2026年9月11日 | 每日 |
| EGLE · Global X Funds | 0.02% | 3 NS | 2026年7月31日 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 30745 SH | 2026年8月19日 | 每日 |
| DYNF · BlackRock ETF Trust | 0.02% | 45056 SH | 2026年9月11日 | 每日 |
| TOPC · iShares Trust | 0.02% | 33 SH | 2026年9月11日 | 每日 |
| XVV · iShares Trust | 0.02% | 647 SH | 2026年9月11日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.02% | 11778 NS | 2026年7月31日 | N-PORT |
| XYLG · Global X Funds | 0.02% | 58 NS | 2026年7月31日 | N-PORT |
| XYLD · Global X Funds | 0.02% | 2904 NS | 2026年7月31日 | N-PORT |
| XRMI · Global X Funds | 0.01% | 44 NS | 2026年7月31日 | N-PORT |
| PTLC · Pacer Funds Trust | 0.01% | 2808 NS | 2026年7月31日 | N-PORT |
| XCLR · Global X Funds | 0.01% | 3 NS | 2026年7月31日 | N-PORT |
| IVV · iShares Trust | 0.01% | 671648 SH | 2026年9月11日 | 每日 |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 308 SH | 2026年10月1日 | 每日 |
| OMFL · Invesco Exchange-Traded Self-Inde... | 0.01% | 3737 SH | 2026年10月1日 | 每日 |
| IWB · iShares Trust | 0.01% | 36488 SH | 2026年9月11日 | 每日 |
| IYY · iShares Trust | 0.01% | 2238 SH | 2026年9月11日 | 每日 |
| SPUU · Direxion Shares ETF Trust | 0.01% | 201 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.01% | 14744 SH | 2026年9月11日 | 每日 |
| QDPL · Pacer Funds Trust | 0.01% | 1283 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.01% | 68363 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.01% | 14968 NS | 2026年7月31日 | N-PORT |
| PHDG · Invesco Actively Managed Exchange... | 0.01% | 42 SH | 2026年10月1日 | 每日 |
| HCMT · Direxion Shares ETF Trust | 0.01% | 369 NS | 2026年7月31日 | N-PORT |
| XTR · Global X Funds | 0.01% | 3 NS | 2026年7月31日 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.01% | 4165 NS | 2026年7月31日 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 1383774 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 1606967 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 41234 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 8402 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 4280 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 11510 SH | 2026年8月19日 | 每日 |
| QVML · Invesco Exchange-Traded Fund Trus... | 0.01% | 879 SH | 2026年10月1日 | 每日 |
| DFLV · Dimensional ETF Trust | 0.00% | 636 NS | 2026年7月31日 | N-PORT |
| GTO · Invesco Actively Managed Exchange... | 0.00% | 3000 | 2026年9月30日 | 每日 |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 2026年7月15日 | 每日 |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 2026年7月15日 | 每日 |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月15日 | 每日 |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月15日 | 每日 |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月30日 | 每日 |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月30日 | 每日 |
| ISCB · iShares Trust | · | 2307 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 11393 SH | 2026年9月11日 | 每日 |
| SMMV · iShares Trust | · | 2436 SH | 2026年9月1日 | 每日 |
UHS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
17 位分析师 · 2026-09-27平均目标 $194.35 +10.6%
同行比较(GICS 子行业) 关键指标与行业同行对比
财年依据,价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存,并会跟随您浏览所有股票。